<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="99186">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01966458</url>
  </required_header>
  <id_info>
    <org_study_id>HW004-A</org_study_id>
    <nct_id>NCT01966458</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL)</brief_title>
  <official_title>A Prospective, Randomized, Controlled, Unblinded, Multi-Center Clinical Trial to Evaluate the HeartWare® Ventricular Assist Device System for Destination Therapy of Advanced Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HeartWare, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HeartWare, Inc.</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, controlled, unblinded, multi-center evaluation of the
      stroke incidence in patients implanted with a HeartWare® HVAD who receive optimal blood
      pressure management. The study compares results of stroke incidence in a new cohort of
      subjects receiving optimal blood pressure management to a reference stroke incidence
      observed in the original IDE clinical trial (HW004) that did not specify optimal blood
      pressure management.

      In addition, a secondary endpoint will evaluate non-inferiority of stroke-free success on
      the originally implanted device to a control group (i.e. any FDA-approved LVAD for
      destination therapy).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in stroke incidence at 12 months on the originally implanted HVAD in a new cohort of subjects receiving optimal blood pressure management.</measure>
    <time_frame>12 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke Free Success</measure>
    <time_frame>12 month</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">429</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>HeartWare® VAS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implant of HeartWare® Ventricular Assist System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control LVAD</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implant of FDA-approved LVAD approved for destination therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HeartWare® VAS</intervention_name>
    <description>The HeartWare® VAS is an implantable centrifugal pump that was designed to provide flows up to 10 L/min in a small device that is both lightweight and simple to use.</description>
    <arm_group_label>HeartWare® VAS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control LVAD</intervention_name>
    <description>Any FDA-approved LVAD for destination therapy.</description>
    <arm_group_label>Control LVAD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Must be ≥18 years of age at consent

          2. Body Surface Area (BSA) ≥ 1.2 m2

          3. Patients with advanced heart failure symptoms (Class IIIB or IV) who are: (patient
             must meet one of the following)a. On optimal medical management, including dietary
             salt restriction and diuretics, for at least 45 out of the last 60 days and are
             failing to respond; or b. In Class III or Class IV heart failure for at least 14
             days, and dependent on intra-aortic balloon pump (IABP) for 7 days and/or inotropes
             for at least 14 days

          4. Left ventricular ejection fraction ≤ 25%

          5. LVAD implant is intended as destination therapy

          6. Must be able to receive either the HeartWare® HVAD or control LVAD

          7. Patient must agree to participate in and comply with an improved blood pressure
             management program, including maintenance of a patient diary.

          8. Female patients of childbearing potential must agree to use adequate contraceptive
             precautions (defined as oral contraceptives, intrauterine devices, surgical
             contraceptives or a combination of condom and spermicide) for the duration of the
             study.

          9. The patient or legally authorized representative has signed the informed consent form

        Exclusion Criteria:

          1. Body Mass Index (BMI) &gt; 40

          2. Existence of any ongoing mechanical circulatory support (MCS) other than an
             intra-aortic balloon pump (IABP)

          3. Prior cardiac transplant.

          4. History of confirmed, untreated abdominal or thoracic aortic aneurysm &gt; 5 cm.

          5. Cardiothoracic surgery within 30 days of randomization.

          6. Acute myocardial infarction within 14 days of implant as diagnosed by ST or T wave
             changes on the ECG, diagnostic biomarkers, ongoing pain and hemodynamic abnormalities
             as described (Figure 2) in the guidelines published in ACC/AHA 2007 Guidelines for
             the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial
             Infarction ;.

          7. Patients eligible for cardiac transplantation

          8. On ventilator support for &gt; 72 hours within the four days immediately prior to
             randomization and implant.

          9. Pulmonary embolus within three weeks of randomization as documented by computed
             tomography (CT) scan or nuclear scan.

         10. Symptomatic cerebrovascular disease, stroke within 180 days of randomization or &gt; 80%
             stenosis of carotid or cranial vessels.

         11. Uncorrected moderate to severe aortic insufficiency.  Correction may include repair
             or bioprosthesis at the time of implant.

         12. Severe right ventricular failure as defined by the anticipated need for right
             ventricular assist device (RVAD) support or extracorporeal membrane oxygenation
             (ECMO) at the time of screening/randomization or right atrial pressure &gt; 20 mmHg on
             multiple inotropes or right ventricular ejection fraction (RVEF) &lt;15% with clinical
             signs of severe right heart failure (e.g. Lower extremity edema, ascites or pleural
             effusions refractory to treatment with diuretics and two inotropic drugs).

         13. Active, uncontrolled infection diagnosed by a combination of clinical symptoms and
             laboratory testing, including but not limited to, continued positive cultures,
             elevated temperature and white blood cell (WBC) count, hypotension, tachycardia,
             generalized malaise despite appropriate antibiotic, antiviral or antifungal
             treatment.

         14. Uncorrected thrombocytopenia or generalized coagulopathy (e.g., platelet count &lt;
             75,000, INR &gt; 2.0 or PTT &gt; 2.5 times control in the absence of anticoagulation
             therapy).

         15. Intolerance to anticoagulant or antiplatelet therapies or any other peri- or
             postoperative therapy that the investigator may administer based upon the patient's
             health status.

         16. Serum creatinine &gt; 3.0 mg/dL within 72 hours of randomization or requiring dialysis
             or ultrafiltration.

         17. Specific liver enzymes [AST (SGOT) and ALT (SGPT] &gt; 3 times upper limit of normal
             within 72 hours of randomization.

         18. A total bilirubin &gt; 3 mg/dl within 72 hours of randomization, or biopsy proven liver
             cirrhosis or portal hypertension.

         19. Pulmonary vascular resistance is demonstrated to be unresponsive to pharmacological
             manipulation and the PVR &gt; 6 Wood units.

         20. Patients with a mechanical heart valve.

         21. Etiology of heart failure is due to, or associated with, uncorrected thyroid disease,
             obstructive cardiomyopathy, pericardial disease, amyloidosis, active myocarditis or
             restrictive cardiomyopathy

         22. History of severe COPD or severe restrictive lung disease (e.g. FEV1 &lt;50%)

         23. Participation in any other study involving investigational drugs or devices

         24. Severe illness, other than heart disease, which would limit survival to &lt; 3 years

         25. Peripheral vascular disease with rest pain or ischemic ulcers of the extremities

         26. Pregnancy

         27. Patient unwilling or unable to comply with study requirements

         28. Technical obstacles, which pose an inordinately high surgical risk, in the judgment
             of the investigator
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francis Pagani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Rogers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dawn Dyer</last_name>
    <email>ddyer@heartware.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jennifer Drummonds</last_name>
      <phone>205-975-9319</phone>
      <email>jdrummonds@uab.edu</email>
    </contact>
    <investigator>
      <last_name>Salpy Pamboukian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic (Arizona)</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sharp Memorial</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suzanne Chillcott</last_name>
      <phone>858-939-3863</phone>
      <email>suzanne.chillcott@sharp.com</email>
    </contact>
    <investigator>
      <last_name>Walter Dembitsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie A. Shinn</last_name>
      <phone>650-723-7319</phone>
      <email>jshinn@stanfordmed.org</email>
    </contact>
    <investigator>
      <last_name>Philip Oyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington DC</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natia Parunashvili</last_name>
      <phone>202-877-9328</phone>
      <email>natia.parunashvili@medstar.net</email>
    </contact>
    <investigator>
      <last_name>Samer Najjar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Florida Gainesville</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nancy Staples</last_name>
      <phone>352-273-5496</phone>
      <email>staplnl@surgery.ufl.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Klodell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Miami / Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Hudson</last_name>
      <phone>305-243-5678</phone>
      <email>ljhudson@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Sandra Chaparro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tampa Transplant Institute/Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint Joseph Hospital of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Allen</last_name>
      <phone>678-843-6081</phone>
      <email>rallen@sjha.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Miller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Emory Clinic Inc.</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Valeroso</last_name>
      <phone>773-834-9021</phone>
      <email>tvaleros@surgery.bsd.uchicago.edu</email>
    </contact>
    <investigator>
      <last_name>Valluvan Jeevanandam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanisha Abraham</last_name>
      <phone>312-926-0846</phone>
      <email>tabraha1@nmh.org</email>
    </contact>
    <investigator>
      <last_name>Edwin McGee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiothoracic &amp; Vascular Surgical Associates</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Gallagher</last_name>
      <phone>708-346-4044</phone>
      <phone_ext>27</phone_ext>
      <email>colleen.gallagher@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>Antone Tatooles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advocate Christ Medical Center</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Gallagher</last_name>
      <phone>708-346-4040</phone>
      <email>colleen.gallagher@advocatehealth.com</email>
    </contact>
    <investigator>
      <last_name>Antone Tatooles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IU Health Methodist</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann-Marie Thorpe</last_name>
      <phone>317-962-9904</phone>
      <email>athorpe2@iuhealth.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Wozniak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jewish Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heather Moody</last_name>
      <phone>502-561-2180</phone>
      <email>hmoody@louisvilleheartsurgery.com</email>
    </contact>
    <investigator>
      <last_name>Mark Slaughter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>John Ochsner Heart &amp; Vascular Institute</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shannon Williams</last_name>
      <phone>504-842-6487</phone>
      <email>slwilliams@ochsner.org</email>
    </contact>
    <investigator>
      <last_name>Patrick Parrino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melanie Her</last_name>
      <phone>410-955-3597</phone>
      <email>mherr@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Gerin Stevens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Linda Romar</last_name>
      <phone>410-328-2737</phone>
      <email>lromar@smail.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Si Pham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan O'Kelly</last_name>
      <phone>617-636-4990</phone>
      <email>rokelly@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Duc Thinh Pham, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lydia McGowan</last_name>
      <phone>734-615-3068</phone>
      <email>lydiamcg@umich.edu</email>
    </contact>
    <investigator>
      <last_name>Francis Pagani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Abbott Northwestern</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carol Toninato</last_name>
      <phone>612-625-4914</phone>
      <email>ctoninato@umphysicians.umn.edu</email>
    </contact>
    <investigator>
      <last_name>Ranjit John, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic / St. Marys Hospital</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Anderson Severson</last_name>
      <phone>507-255-2673</phone>
      <email>severson.cathy@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Lyle Joyce, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University / Barnes Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Sutton</last_name>
      <phone>314-747-1926</phone>
      <email>suttont@wudosis.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Scott Silvestry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newark Beth Israel Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bhatri Patel</last_name>
      <phone>973-926-8451</phone>
      <email>bharapatel@barnabashealth.org</email>
    </contact>
    <investigator>
      <last_name>Mark Zucker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gillian Morgan</last_name>
      <phone>718-920-6742</phone>
      <email>gimorgan@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Daniel Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital/Columbia</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Blue</last_name>
      <phone>919-681-1779</phone>
      <email>blue0001@mc.duke.edu</email>
    </contact>
    <investigator>
      <last_name>Carmelo Milano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundatiojn</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly MacBrair</last_name>
      <phone>614-366-7446</phone>
      <email>Kelly.MacBrair@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>C.B. Sai-Sudhakar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudia Stone</last_name>
      <phone>503-494-4192</phone>
      <email>stonecl@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Howard Song, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dale Kobrin</last_name>
      <phone>215-300-7456</phone>
      <email>Dale.Kobrin@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Acker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Presbyterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sylvia A. Carranza</last_name>
      <phone>832-355-8524</phone>
      <email>SCarranza@texasheart.org</email>
    </contact>
    <investigator>
      <last_name>Hari Mallidi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Raquel R. Bunge</last_name>
      <phone>713-441-6509</phone>
      <email>rrbunge2@tmhs.org</email>
    </contact>
    <investigator>
      <last_name>Brian Bruckner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marsha Eidson</last_name>
      <phone>801-408-8666</phone>
      <email>marsha.eidson@imail.org</email>
    </contact>
    <investigator>
      <last_name>Bruce Reid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Washington Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shauna Andrus</last_name>
      <phone>206-221-5895</phone>
      <email>sandrus@u.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Nahush Mokadam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Cardiothoracic &amp;Transplant Surgeons</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Aurora St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl A. Zywicki</last_name>
      <phone>414-385-2474</phone>
      <email>cheryl.zywicki@aurora.org</email>
    </contact>
    <investigator>
      <last_name>Francis Downey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>May 2, 2014</lastchanged_date>
  <firstreceived_date>October 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
